- Home
- BHVN vs ESE Comparison
BHVN vs ESE Comparison
Compare BHVN & ESE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- ESE
- Stock Information
- Founded
- BHVN 2013
- ESE 1990
- Country
- BHVN United States
- ESE United States
- Employees
- BHVN N/A
- ESE N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- ESE Telecommunications Equipment
- Sector
- BHVN Health Care
- ESE Telecommunications
- Exchange
- BHVN Nasdaq
- ESE Nasdaq
- Market Cap
- BHVN 1.9B
- ESE N/A
- IPO Year
- BHVN 2017
- ESE N/A
- Fundamental
- Price
- BHVN $20.25
- ESE $173.83
- Analyst Decision
- BHVN Strong Buy
- ESE Strong Buy
- Analyst Count
- BHVN 14
- ESE 2
- Target Price
- BHVN $62.92
- ESE $182.50
- AVG Volume (30 Days)
- BHVN 2.2M
- ESE 173.4K
- Earning Date
- BHVN 05-16-2025
- ESE 05-07-2025
- Dividend Yield
- BHVN N/A
- ESE 0.18%
- EPS Growth
- BHVN N/A
- ESE 19.62
- EPS
- BHVN N/A
- ESE 4.56
- Revenue
- BHVN N/A
- ESE $1,071,861,000.00
- Revenue This Year
- BHVN N/A
- ESE $11.52
- Revenue Next Year
- BHVN $65.26
- ESE $17.21
- P/E Ratio
- BHVN N/A
- ESE $38.11
- Revenue Growth
- BHVN N/A
- ESE 8.40
- 52 Week Low
- BHVN $15.79
- ESE $101.42
- 52 Week High
- BHVN $55.70
- ESE $179.42
- Technical
- Relative Strength Index (RSI)
- BHVN 43.84
- ESE 67.49
- Support Level
- BHVN $18.99
- ESE $161.61
- Resistance Level
- BHVN $24.06
- ESE $166.85
- Average True Range (ATR)
- BHVN 2.03
- ESE 4.64
- MACD
- BHVN 0.24
- ESE 1.86
- Stochastic Oscillator
- BHVN 42.62
- ESE 83.72
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.